The 2017 International Conference and Expo on Biotechnology and Healthcare will be held during October 26-27, 2017 in Hyderabad, India. Biotechconference 2017 is to amalgamate innovative academics and industrial experts in the field of Biotechnology and Healthcare to a common forum.
The idiopathic goal of the conference is to promote research and developmental activities in Biotechnology and Healthcare and to encourage scientific information interchange between researchers, developers, students, and practitioners working in India and Abroad. This will also provide you an opportunity to share knowledge and channels for extending businesses between industry and academia.
This conference subjected to discussion and throw light on latest researches on animal biotechnology, agricultural biotechnology, environmental biotechnology, genomics, business models, pharmaceutical biotechnology, medical biotechnology, stem-cell biotechnology, cancer biology, genetics, transgenic plant and crops, bioremediation, health care economics, health services, health policy, medical ethics and healthcare technology.
The Biotechnology sector is being accosted as the up surging sector of India. It has been making substantial progress over the last few years and has the potential to emerge as a global leader in the biotech industry.
The Indian biotech sector marked the target of 5$ billion in revenue by fiscal 2010-11. The Indian government's Department of Biotechnology conveys that the Indian Biotech Industry witnessed the YoY growth of 57.14 per cent in FY16; the total industry size stood at US$ 11 billion by FY16 and is estimated to reach US$ 11.6 billion by FY17.
Today in India there are more than 350 renowned Biotechnology companies in India providing employment for over 20, 000 scientists.
Serum Institute of India
Krebs Biochemicals and Industries limited
Indian Biotechnology Bio-pharma accounts for majority market share. The industry has be classified into five different segments: Biopharma, Agri Biotech, Bioinformatics, bio-industrial and Bio services with each concentrating on the particular area, as bio-pharmaceutical segment accounted for largest revenue share of 64 per cent in India biotech industry, during FY16, while the bio-services and bio-agri segments accounted for 18.0 per cent and 14.0 per cent respectively in FY16. In upcoming years India is becoming a leading destination for clinical trials, contract research and manufacturing activities which are leading to the growth of other sectors as well.
India is ranked among the top 12 Biotech destinations in the world and is the third biggest in Asia Pacific in terms of the number of biotech companies. Investments in the segments are also growing at the rate of about 38% for the last three years and have reached the 560 million dollars in 2006-2007.
Larger biotechnology companies are making decisions of that type around the globe. Today biotechnology knows no boundaries. Several regions of the world have set out to emulate such as:
Asia Pacific: In 2015, Biotechnology market is in between US$700 billion and US$950 billion in revenue was generated by this medium also, it is anticipated that in 2018, this online market will generate revenue nearly 25% more than the previous.
Europe: The European biotech industry offers employment to approximately 95,000 people. Europe spends nearly $7.32 billion in R&D and $23.2 billion in revenue. Nearly 20% of the total marketed medicines, and as much as 50% of all drugs that are in the pipeline, are all healthcare biotech products.
USA: The USA biotechnology industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. North America dominated the revenue share in 2015 with over USD 137.4 billion owing to growing R&D initiatives by key industry players and rising awareness among public and private research institute.
Middle East: Initially biotechnology market was trade deficit is near US$8 billion, its external debt market is expected to grow to more than US$31.6 billion during the forecast period 2016-2019. Middle East market provides pharmaceuticals biotechnology with a direct channel and in turn prime solutions to Healthcare sector in major regions such Dubai and Cairo